Related Experiment Video
Updated: Dec 27, 2025
Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates
Published on: July 6, 2013
Preventing Infection by Human Cytomegalovirus
1Department of Pediatrics, University of Pennsylvania, Vaxconsult, Doylestown, Pennsylvania, USA.
Developing a human cytomegalovirus (CMV) vaccine is challenging due to the virus's complex biology. Promising vaccine candidates show potential in protecting certain populations, with future studies assessing their efficacy against congenital CMV infection.
Area of Science:
- Virology
- Immunology
- Vaccinology
Background:
- Human cytomegalovirus (CMV) infection presents unique biological challenges for vaccine development.
- Despite these hurdles, progress has been made in identifying potential vaccine candidates.
Purpose of the Study:
- To evaluate the efficacy of candidate vaccines against human cytomegalovirus.
- To determine if these vaccines can prevent congenital CMV infection.
Main Methods:
- Clinical trials involving seronegative women and transplant recipients.
- Ongoing research to assess vaccine effectiveness in preventing congenital transmission.
Main Results:
- Candidate vaccines have demonstrated protective effects in seronegative women and transplant recipients.
- Further data is anticipated regarding the prevention of congenital CMV infection.
Conclusions:
- The peculiar biology of CMV infection complicates vaccine development.
- Emerging vaccine candidates offer hope for protection, particularly against congenital transmission.
More Related Videos
08:08qPCR Is a Sensitive and Rapid Method for Detection of Cytomegaloviral DNA in Formalin-fixed, Paraffin-embedded Biopsy Tissue
Published on: July 9, 2014
10:24Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System
Published on: October 5, 2015
Related Concept Videos
01:26Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
01:22Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
01:20Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
01:25Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
01:17Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
01:23Hand hygiene
Hand washing...